Baudax Bio, Inc.
BXRXQ · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | -1,445.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -2,442.3% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | – | – | – | -2,983.9% |
| EPS Diluted | -0.3 | -1.51 | 4.91 | -12.33 |
| % Growth | 80.1% | -130.8% | 139.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |